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Abstract
Background: Welding fume has been categorized as "possibly carcinogenic" to humans. Our
objectives were to characterize the lung response to carcinogenic and non-carcinogenic metal-
containing welding fumes and to determine if these fumes caused increased lung tumorigenicity in
A/J mice, a lung tumor susceptible strain. We exposed male A/J and C57BL/6J, a lung tumor
resistant strain, by pharyngeal aspiration four times (once every 3 days) to 85 μg of gas metal arc-
mild steel (GMA-MS), GMA-stainless steel (SS), or manual metal arc-SS (MMA-SS) fume, or to 25.5
μg soluble hexavalent chromium (S-Cr). Shams were exposed to saline vehicle. Bronchoalveolar
lavage (BAL) was done at 2, 7, and 28 days post-exposure. For the lung tumor study, gross tumor
counts and histopathological changes were assessed in A/J mice at 48 and 78 weeks post-exposure.
Results: BAL revealed notable strain-dependent differences with regards to the degree and
resolution of the inflammatory response after exposure to the fumes. At 48 weeks, carcinogenic
metal-containing GMA-SS fume caused the greatest increase in tumor multiplicity and incidence,
but this was not different from sham. By 78 weeks, tumor incidence in the GMA-SS group versus
sham approached significance (p = 0.057). A significant increase in perivascular/peribronchial
lymphoid infiltrates for the GMA-SS group versus sham and an increased persistence of this fume
in lung cells compared to the other welding fumes was found.
Conclusion: The increased persistence of GMA-SS fume in combination with its metal
composition may trigger a chronic, but mild, inflammatory state in the lung possibly enhancing
tumorigenesis in this susceptible mouse strain.
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For decades researchers have tried to determine whether
exposure to welding fumes poses an increased risk of lung
cancer. Indeed, this health concern is one of the most
important questions in welding fume-related toxicologi-
cal research. The International Agency for Research on
Cancer has deemed welding fume a group 2B agent,
defined as a mixture "possibly carcinogenic" to humans
[1]. This categorization of welding fume carcinogenicity,
however, was based on limited evidence in humans and a
lack of animal data.
The harmful health effects of welding are well docu-
mented and epidemiological evidence generally supports
the hypothesis that exposure to welding fume increases
lung cancer risk, but confounders such as asbestos expo-
sure and smoking obscure these findings [2-5]. Debate
also exists over which type of welding may pose the
greater risk. Interestingly, fumes from both non-carcino-
genic metal-containing mild steel (MS) and carcinogenic
metal-containing stainless steel (SS) welding wire have
been shown to increase lung cancer risk in welders [6,7].
For these reasons, we initiated a multipart study to ulti-
mately determine the carcinogenic potential of SS and MS
welding fumes in an animal model.
Electric arc welding joins pieces of metal that are rendered
liquid by heat. Arc temperatures above 4000°C heat the
base metal pieces to be joined and the consumable elec-
trode wire that is continuously fed into the weld. The
vaporized metals, derived primarily from the wire, react
with air and form the fume, which consists of a complex
mixture of metal oxides. Depending on the welding proc-
ess employed, the electrode coating, shielding gases,
fluxes, base metal, and paint or surface coatings also may
comprise the welding fume [8].
Among the numerous types of welding processes, manual
metal arc (MMA) and gas metal arc (GMA) welding are
two types commonly used in the workplace. Welding
processes that use SS wire produce fumes that contain car-
cinogenic metals such as chromium (Cr) and nickel (Ni).
Welding fume from MS wire primarily consists of iron
(Fe) with a lesser amount of manganese (Mn), but no Cr
or Ni. In addition, fumes from MMA-SS wire yield more
water-soluble metals in suspension than GMA-SS or
GMA-MS fumes and consequently, in animal models,
induced a more potent acute lung toxicity [9,10].
In this investigation, we used lung tumor susceptible A/J
mice, a common animal model for lung carcinogenesis
studies. Compared to the essentially lung tumor resistant
C57BL/6J strain, A/J mice exhibit high susceptibility to
spontaneous and chemically induced lung tumors [11].
Further, the lung tumors in the A/J mouse display many
morphological, histopathological, and molecular similar-
ities to human pulmonary adenocarcinomas, which
makes them a relevant model for lung cancer research
[12,13].
Our first objective was to characterize the potential of
welding fumes of different metal compositions, or com-
ponents thereof, to cause acute lung toxicity in lung tumor
susceptible (A/J) and resistant (C57BL/6J) mice. We
rationalized that this direct strain comparison would be
invaluable for interpretation of our second objective
which was to determine the tumorigenic potential of
these different welding fumes in the susceptible A/J
mouse model.
Results
Bronchoalveolar lavage (BAL) findings 2 days after 
exposure: GMA-MS and GMA-SS
GMA-MS welding fume caused a similar degree of lung
cell death (measured as lactate dehydrogenase activity
[LDH]) in both strains and no significant epithelial dam-
age (measured as albumin) compared to the correspond-
ing sham (Table 1). The recovered BAL %
polymorphonuclear leukocytes (PMN) was two-fold
greater in the A/J compared to the C57BL/6J strain while
lymphocytes were not elevated in response to this fume in
either strain. GMA-SS exposure was more toxic to the A/J
than the GMA-MS fume. Significant lung epithelial dam-
age and cell death occurred in both strains with the A/J
having a ~1.7 fold greater response. The %PMN was mark-
edly higher in the A/J strain (44%) versus the C57BL/6J
(9%) and lymphocytes were equally elevated in both
strains. No strain differences were found for increased
macrophage/monocytes in the BAL, but a significant
increase in number was observed for the C57BL/6J strain
following GMA-SS exposure only (data not shown).
BAL findings 2 days after exposure: MMA-SS and soluble 
chromium (S-Cr)
At 2 days post-exposure, both mouse strains had signifi-
cant lung cell death and epithelial damage following
MMA-SS or S-Cr exposure (Table 1). MMA-SS fume was a
greater inducer of cell death in the A/J and this was also
significantly greater in comparison to the MMA-SS-
exposed C57BL/6J strain (~1.5 fold). LDH levels between
the MMA-SS and S-Cr exposures were not different in the
C57BL/6J. The A/J had significantly greater epithelial
damage following MMA-SS exposure compared to the
C57BL/6J strain as shown by the increased albumin in the
BAL. The C57BL/6J exhibited more epithelial damage
than the A/J strain following S-Cr exposure although this
was not a consistent finding for other markers of toxicity
in this study. Both exposures caused a significant increase
in %PMN at 2 days in both mouse strains compared to the
corresponding sham (Table 1). The C57BL/6J strainPage 2 of 16
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imately a 9% increase in BAL PMN. The C57BL/6J had
~2% increase in lymphocytes following the exposures,
which was greater than both exposed A/J groups. In con-
trast, the A/J mice had a significantly greater response to
MMA-SS (~40% PMN) but responded similarly to the
C57BL/6J following S-Cr exposure (~11% PMN). Of note,
although treatment effects were found for increased lung
macrophage/monocytes in both strains following MMA-
SS exposure, no strain differences were found for this
inflammatory parameter (data not shown).
BAL findings 7 days after exposure: GMA-MS and GMA-SS
By 7 days post-exposure, LDH remained significantly ele-
vated in both mouse strains exposed to GMA-MS welding
fume (Table 2). At this time point, the A/J mice had signif-
icantly greater LDH levels compared to the C57BL/6J
strain. As with the earlier time point, no indication of epi-
thelial damage occurred with this fume. The %PMN
remained significantly elevated only in the A/J strain at 7
days (~12%). The GMA-SS fume caused a greater LDH and
%PMN response in the A/J compared to the C57BL/6J. At
7 days, this fume was again more toxic to the A/J com-
pared to the MS fume. No strain differences were found
for increased lymphocytes or macrophage/monocytes,
although a mild elevation versus the corresponding
Table 1: Bronchoalveolar lavage parameters 2 days post-exposure
Mouse Strain n Exposure %Albumin§ %LDH§ %Lymphocytes|| %PMN||
A/J 7 GMA-MS 126 ± 4 155 ± 7* 0.8 ± 0.4 (0.2 ± 0.13) 24 ± 3*‡ (1.1 ± 1.1)
C57BL/6J 7 GMA-MS 109 ± 3 134 ± 10* 1.3 ± 0.8 (0.3 ± 0.1) 12 ± 3* (0.05 ± 0.05)
A/J 7 GMA-SS 229 ± 13*†‡ 307 ± 12*†‡ 2.2 ± 0.8*† (0.2 ± 0.13) 44 ± 3*†‡ (1.1 ± 1.1)
C57BL/6J 6 GMA-SS 139 ± 13*† 176 ± 16* 2.1 ± 0.2* (0.3 ± 0.1) 9 ± 2* (0.05 ± 0.05)
A/J 7 MMA-SS 331 ± 26*†‡ 343 ± 33*†‡ 0.1 ± 0.06 (0.06 ± 0.06) 41 ± 4*†‡ (0.7 ± 0.6)
C57BL/6J 7 MMA-SS 218 ± 16* 230 ± 25* 1.6 ± 0.24*‡ (0 ± 0) 9 ± 2* (0.2 ± 0.08)
A/J 7 S-Cr 209 ± 10* 178 ± 14* 0.5 ± 0.16*† (0.06 ± 0.06) 11 ± 0.8* (0.7 ± 0.6)
C57BL/6J 7 S-Cr 266 ± 25*†‡ 182 ± 20* 2 ± 0.6*‡ (0 ± 0) 9 ± 3* (0.2 ± 0.08)
*Significantly different from corresponding sham; †Between exposed groups of the same mouse strain; ‡Between mouse strains of the same 
exposure group (p < 0.05)
§LDH and albumin data are represented as % corresponding sham.
||Percentage from a differential cell count of > 300 cells with the corresponding sham % in parentheses. Note. Data are means ± SE. Statistical 
comparisons were MMA-SS and S-Cr or GMA-MS and GMA-SS. Abbreviations are GMA-MS-gas metal arc-mild steel, GMA-SS-gas metal arc 
stainless steel, or MMA-SS-manual metal arc stainless steel welding fume; S-Cr-soluble chromium VI; LDH-lactate dehydrogenase; PMN-
polymorphonuclear leukocytes
Table 2: Bronchoalveolar lavage parameters 7 days post-exposure
Mouse Strain n Exposure %Albumin§ %LDH§ %Lymphocytes|| %PMN||
A/J 7 GMA-MS 90 ± 3 156 ± 10*‡ 0.64 ± 0.16 (0 ± 0) 12 ± 1.2*‡ (0 ± 0)
C57BL/6J 7 GMA-MS 105 ± 3 132 ± 3* 0.54 ± 0.13 (0.14 ± 0.07) 0.72 ± 0.3 (0.05 ± 0.05)
A/J 6 GMA-SS 115 ± 6 216 ± 16* †‡ 0.86 ± 0.18* (0 ± 0) 20 ± 1.2*†‡ (0 ± 0)
C57BL/6J 7 GMA-SS 113 ± 4 148 ± 8* 0.8 ± 0.17 * (0.14 ± 0.07) 1.3 ± 0.8 (0.05 ± 0.05)
A/J 7 MMA-SS 145 ± 11* 144 ± 17* 1.8 ± 0.5* (0.1 ± 0.06) 12 ± 1.0*†‡ (0.1 ± 0.1)
C57BL/6J 7 MMA-SS 115 ± 8 130 ± 5*† 1.0 ± 0.36* (0 ± 0) 1.6 ± 0.1*† (0.07 ± 0.07)
A/J 5 S-Cr 137 ± 12* 111 ± 13 2.2 ± 0.46* (0.1 ± 0.06) 5.6 ± 0.6*‡ (0.1 ± 0.1)
C57BL/6J 7 S-Cr 124 ± 8* 111 ± 7 0.44 ± 0.23 (0 ± 0) 0.22 ± 0.2 (0.07 ± 0.07)
*Significantly different from corresponding sham; † Between exposed groups of the same mouse strain; ‡Between mouse strains of the same 
exposure group (p < 0.05)
§LDH and albumin data are represented as % corresponding sham. ||Percentage from a differential cell count of > 300 cells with the corresponding 
sham % in parentheses.
Note. Data are means ± SE. Statistical comparisons were MMA-SS and S-Cr or GMA-MS and GMA-SS. Abbreviations are GMA-MS-gas metal arc-
mild steel, GMA-SS-gas metal arc stainless steel, or MMA-SS-manual metal arc stainless steel welding fume; S-Cr-soluble chromium VI; LDH-lactate 
dehydrogenase; PMN-polymorphonuclear leukocytesPage 3 of 16
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data not shown).
BAL findings 7 days after exposure: MMA-SS and S-Cr
No strain differences were observed for LDH or albumin
at 7 days post-exposure to MMA-SS fume, although both
parameters remained significantly elevated in the A/J,
only LDH remained increased in the C57BL/6J (Table 2).
Both strains in the S-Cr-exposed groups had increased
albumin but no strain differences were noted. Significant
strain differences were evident for %PMN influx. MMA-SS
caused a more pronounced effect in the A/J strain with
~12% PMN versus ~6% in the S-Cr-exposed mice, while
only a mild elevation was found for the exposed C57BL/
6J groups. No strain differences were found for increased
macrophage/monocytes, but an unremarkable increase in
number was found in the MMA-SS groups (data not
shown).
BAL findings 28 days after exposure: GMA-MS and GMA-
SS
By 28 days, LDH and albumin had returned to baseline in
all groups exposed to GMA-MS (data not shown). The
only strain difference noted was the PMN response which
remained at ~10% in the A/J mice versus ~1% in the
C57BL/6J. The A/J mice continued to have significant lung
cell death, lymphocyte and PMN influx associated with
GMA-SS exposure, and these responses were ~1.2–2 fold
greater in comparison to the GMA-MS fume. The A/J
strain exhibited a 9 fold greater %PMN response com-
pared to the C57BL/6J following exposure to GMA-SS.
BAL findings 28 days after exposure: MMA-SS and S-Cr
At 28 days post-exposure, LDH and albumin were not sig-
nificantly elevated in the MMA-SS or S-Cr exposed groups
of either strain (data not shown). Only the MMA-SS-
exposed A/J mice had significant PMN in the BAL, approx-
imately 4.4%.
Of note, for all groups, no strain differences were found
for any BAL parameter in the sham mice at any time point.
BAL inflammatory cytokine and lung gene expression 
analysis
The first fraction BAL supernatant was used to determine
the protein levels of interferon-γ (IFN-γ), interleukin-6
(IL-6), interleukin-10 (IL-10), interleukin-12p70 (IL-
12p70), monocyte chemoattractant protein-1 (MCP-1),
and tumor necrosis factor-α (TNF-α) at 2, 7, and 28 days
post-exposure to MMA-SS fume or S-Cr. Protein levels of
IL-10 and IL-12p70 were unaltered by either exposure
(data not shown).
IFN-γ protein was increased following MMA-SS exposure
in the A/J but not the C57BL/6J mice at 2 days (Figure 1A).
By 7 days post-exposure, these levels remained moder-
ately elevated (data not shown). No IFN-γ protein was
detected in the C57BL/6J strain for either exposure at this
time point. Whole lung gene expression confirmed these
findings in the MMA-SS-exposed A/J mice. A mild increase
in gene expression was found for the MMA-SS-exposed
C57BL/6J mice but this was significantly less than levels
found in the exposed A/J strain (Figure 1B). IL-6 protein
was increased following S-Cr and MMA-SS exposure at 2
days in both strains (Figure 1C). The C57BL/6J responded
equally to both exposures while the mean response to the
MMA-SS was greater in the A/J mice. Gene expression con-
firmed these data as the A/J showed approximately a two
fold greater increase in IL-6 mRNA compared to the
C57BL/6J (Figure 1D). By 7 days, gene expression had
returned to baseline and protein levels declined with a
slight elevation remaining in the MMA-SS-exposed A/J
strain (data not shown). By 28 days, protein levels were
undetectable in all groups for both IFN-γ and IL-6 (data
not shown). No differences were found between the two
strains for gene expression levels in the shams at either
time point.
A similar trend was found for protein and gene expression
levels of MCP-1 and TNF-α (Figure 2). The A/J mice con-
sistently had a greater response to MMA-SS compared to
S-Cr and the C57BL/6J strain at 2 days post-exposure (Fig-
ure 2A &2C). Gene expression for MCP-1 and TNF-α
revealed at least a two fold induction difference between
the strains (Figure 2B &2D). By 7 days, gene expression
returned to baseline while protein levels decreased but
remained mildly elevated in the exposed A/J mice (data
not shown). By 28 days, protein levels were undetectable
in all groups for MCP-1 and TNF-α (data not shown). In
addition, no differences were found between the two
strains for gene expression levels in the saline shams at
either time point.
The first fraction BAL supernatant was used to determine
the protein levels of IFN-γ, IL-6, IL-10, IL-12p70, MCP-1,
and TNF-α at 2, 7, and 28 days post-exposure to GMA
welding fumes. Data are shown only for MCP-1 and TNF-
α at the 2 and 28 day time points (Figure 3A–D); the IFN-
γ, IL-6, and 7 day data are described below. No trends
were found in either strain for IL-10 and IL-12p70 protein
(data not shown).
IFN-γ protein was increased following GMA-SS fume
exposure (9.0 ± 2.4 pg/ml) only in the A/J at 2 days post-
exposure but was undetectable by day 7. IL-6 protein was
greater in the GMA-SS-exposed A/J compared to the
C57BL/6J at 2 days (23.3 ± 1.8 and 15.5 ± 5.3 pg/ml,
respectively) and levels remained elevated at 7 days in the
A/J (12.5 ± 2.6 pg/ml). By 28 days, IL-6 levels were unde-
tectable in the A/J. GMA-MS exposure did not increasePage 4 of 16
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sure (data not shown).
MCP-1 protein levels were increased following GMA-SS
exposure at 2, 7, and 28 days in the A/J strain while the
C57BL/6J only had elevated levels at day 2 (Figure 3A
&3B). GMA-MS fume did not affect BAL levels of MCP-1
at any time point in either strain. TNF-α levels in the
GMA-SS-exposed A/J were elevated at 2 (Figure 3C) and 7
days post-exposure and remained mildly elevated at 28
days (Figure 3D). The C57BL/6J had lower TNF-α levels at
2 and 7 days post-exposure and no detectable levels by 28
days. At 2 (Figure 3D) and 7 days, GMA-MS fume did
increase BAL TNF-α levels in the A/J strain, although levels
were lower in comparison to GMA-SS.
Lung oxidative stress
No increased gene expression was found for prostaglan-
din-endoperoxide synthase 2 (COX-2), nitric oxide syn-
thase 2 (iNOS or NOS2), or glutathione-S-transferase Pi
(GST-Pi) at the 2 day time point for either mouse strain
exposed to MMA-SS fume (data not shown). S-Cr samples
were not analyzed because no strain differences were
found by other parameters in this study. At 28 days, GMA
or MMA-SS fumes did not cause increased expression of
GST-Pi or COX-2 genes in the A/J (data not shown). Gene
expression in the C57BL/6J was not analyzed at 28 days as
Effect of S-Cr or MMA-SS welding fume on lavage protein levels and whole lung gene expression of IFN-γ (A&B) and IL-6 (C&D) at 2 days post-exposure in A/J and C57BL/6J miceFigure 1
Effect of S-Cr or MMA-SS welding fume on lavage protein levels and whole lung gene expression of IFN-γ 
(A&B) and IL-6 (C&D) at 2 days post-exposure in A/J and C57BL/6J mice. The dotted line represents the assay sen-
sitivity for each protein and mean lines (–) are shown for each group. Gene expression data are presented as fold change from 
sham controls (dotted line). Values are mean ± SE (n = 4–7 per group). *-Significantly different from corresponding sham. #-
Significantly different between strains of the same exposure group Note: Portions of this figure have been previously published [42].Page 5 of 16
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point (data not shown).
Effects on body weight and survival 48 and 78 weeks after 
welding fume exposure
Fluctuations in body weight (± 1–2 g) occurred in all
groups, but no effects on final body weight were observed
due to welding fume exposure (data not shown). At the 48
and 78 week sacrifices, respectively, mice had gained an
average (± SE) of 7.3 ± 0.63 g and 7.6 ± 0.20 g over the
course of the study.
Survival was not different between any welding fume-
exposed group and shams at either time point. At 48
weeks post-exposure, survival was > 91% for all groups. At
78 weeks, survival was 80% for the sham, GMA-MS and
MMA-SS groups, and 73% for the GMA-SS group.
Urethane positive control findings
Urethane exposed A/J mice had an average lung tumor
multiplicity of 17.2 ± 0.97 (tumors/lung, n = 24) and
100% (24/24) incidence at 48 weeks. The survival rate
was 96% at 48 weeks post-exposure. Due to the observed
carcinogenic potency of urethane the 78 week group was
Effect of S-Cr or MMA-SS welding fume on lavage protein levels and whole lung gene expression of MCP-1 (A&B) and TNF-α (C&D) at 2 days post-exposure in A/J and C57BL/6J miceFigure 2
Effect of S-Cr or MMA-SS welding fume on lavage protein levels and whole lung gene expression of MCP-1 
(A&B) and TNF-α (C&D) at 2 days post-exposure in A/J and C57BL/6J mice. The dotted line represents the assay 
sensitivity for each protein and mean lines (–) are shown for each group. Gene expression data are presented as fold change 
from sham controls (dotted line). Values are mean ± SE (n = 4–7 per group). *-Significantly different from corresponding sham. 
Note: Portions of this figure have been previously published [42].Page 6 of 16
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Effect of GMA welding fumes on lavage protein levels of MCP-1 (A&B) and TNF-α (C&D) at 2 and 28 days post-exposure in A/J and C57BL/6J miceFigure 3
Effect of GMA welding fumes on lavage protein levels of MCP-1 (A&B) and TNF-α (C&D) at 2 and 28 days 
post-exposure in A/J and C57BL/6J mice. The dotted line represents the assay sensitivity for each inflammatory protein 
and mean lines (–) are shown for each group (n = 5–7).
Table 3: Gross lung tumor findings for A/J mice 48 and 78 weeks post-exposure
Exposure Lung Tumor Multiplicity* Lung Tumor Incidence†
48 wk 78 wk 48 wk 78 wk
Sham 0.38 ± 0.13 (21) 1.00 ± 0.35 (19) 33% (7/21) 53% (10/19)
GMA-MS
Gas metal arc-mild steel
0.42 ± 0.14 (24) 1.00 ± 0.22 (20) 33% (8/24) 65% (13/20)
GMA-SS
Gas metal arc-stainless steel
0.45 ± 0.14 (20) 1.75 ± 0.32 (16) 40% (8/20) 81% (13/16)
MMA-SS
Manual metal arc-stainless steel
0.25 ± 0.11 (24) 1.55 ± 0.34 (20) 21% (5/24) 80% (16/20)
*Average number of tumors per lung (± SE) and includes mice with no tumors. Parentheses indicate total animal number. †Percentage of tumor-
bearing mice out of the total. Parentheses indicate tumor-bearing/total animal number.
Particle and Fibre Toxicology 2008, 5:12 http://www.particleandfibretoxicology.com/content/5/1/12sacrificed at 54 weeks. Survival had decreased to 85% by
this time point post-exposure. Tumor multiplicity and
incidence was 15.41 ± 1.64 (tumors/lung, n = 17) and
94% (16/17 mice), respectively.
Gross tumor findings in A/J mice 48 and 78 weeks after 
welding fume exposure
At 48 weeks post-exposure, lung tumor multiplicity and
incidence was greatest in the GMA-SS-exposed group
(0.45 ± 0.14 and 40%, respectively) (Table 3). However,
at this time point, statistical significance was not achieved.
Shams had a 33% tumor incidence and a 0.38 ± 0.13 mul-
tiplicity upon gross exam. Increases in lung tumor inci-
dence or multiplicity following exposure to GMA-MS or
MMA-SS welding fumes were unremarkable. Average
tumor size was ≤ 2 mm for all groups at 48 weeks.
At 78 weeks, exposure to both SS welding fumes increased
tumor multiplicity and incidence compared to sham and
the GMA-MS fume, but this increase did not reach statisti-
cal significance (Table 3). However, gross tumor incidence
between the GMA-SS and sham groups was 81% and
53%, respectively, and approached significance (p =
0.057). The tumor multiplicity in the GMA-SS was greater
in comparison to all groups and was 1.75 ± 0.32 versus
1.00 ± 0.35 in the sham. No significant differences in
tumor multiplicity or incidence were found for the MMA-
SS or GMA-MS-exposed groups versus sham control. Aver-
age tumor size varied between 2.4–3.5 mm at 78 weeks,
and was not different among exposure groups.
Lung histopathological findings in A/J mice 48 and 78 
weeks after welding fume exposure
In addition to the gross tumor evaluation at necropsy, his-
topathological analysis was done on separately embedded
lung lobes from all mice in the study to evaluate morpho-
logical changes (Table 4). At 48 weeks post-exposure, all
lung lesions observed were either adenomas or preneo-
plastic epithelial proliferations (Figure 4A &4B). The
GMA-SS group had the greatest increase in preneoplasia/
tumor multiplicity and incidence (0.75 ± 0.15 and 65%).
This was significantly different compared to the GMA-MS
group (33%), but not sham (50%). Significance for inci-
dence between the MMA-SS versus GMA-SS groups was
borderline (p = 0.06). A significant increase in welding
fume-containing macrophages was found in all exposed
groups. GMA-SS welding fume was consistently found, in
moderate amounts (3.03 ± 0.13), in all five lung lobes of
all 20 mice evaluated whereas MMA-SS and GMA-MS
fumes were variable and minimal in the lung, 0.67 ± 0.13
and 0.34 ± 0.10, respectively (Figure 4C). The presence of
perivascular/peribronchial lymphoid infiltrates in the
lung was not a significant finding at 48 weeks post-expo-
sure to welding fume.
By 78 weeks, tumor/preneoplastic lesions were observed
in lungs of all groups and primarily were preneoplastic
epithelial proliferations, adenomas, and adenomas aris-
ing within proliferations (Table 4). Carcinomas arising in
an adenoma, carcinomas, and microcarcinomas were also
observed but were less common. Again, multiplicity and
incidence was greatest in the GMA-SS group, 1.94 ± 0.38
and 88%, respectively. This was not statistically different
compared to multiplicity and incidence in the shams,
1.47 ± 0.33 and 68%, respectively. There was no associa-
tion noted between the presence of any welding fume and
preneoplastic or neoplastic lesions in the lung at 78 weeks
after exposure.
The GMA-SS group also exhibited a significant increase in
perivascular/peribronchial associated lymphoid infil-
trates – composed of lymphocytes, macrophages, and
plasma cells – at 78 weeks post-exposure (Figure 4D).
These lung infiltrates, however, were not necessarily asso-
ciated with the presence of GMA-SS fume particles in the
lung. GMA-SS welding fume was present in most lung
lobes of all the mice in that group and in twice the
amount, as shown by the increased presence of welding
fume-laden cells, compared to the other fumes. The GMA-
MS and MMA-SS fumes were rarely observed in the lung
at 78 weeks post-exposure.
Discussion and conclusion
This study compared the lung response in lung tumor sus-
ceptible (A/J) and resistant (C57BL/6J) mice exposed to
GMA-MS, GMA-SS, MMA-SS, and S-Cr and found notable
strain-dependent differences with regards to the degree
and resolution of the inflammatory response. We also
found supportive, but not conclusive, evidence for a pos-
sible tumorigenic effect of GMA-SS welding fume in the
lung tumor susceptible A/J mouse. The results of this
study, however, did not suggest a tumorigenic effect of
MMA-SS or GMA-MS welding fumes. To our knowledge,
this is the first in vivo animal study to provide preliminary
evidence for a possible association between welding fume
exposure and lung tumorigenesis.
The A/J mouse model was chosen based on its similarities
with human lung adenocarcinoma development-specifi-
cally, the anatomy, histogenesis, and molecular features
[12]. For example, the pulmonary adenoma susceptibility
(Pas1) locus, a major mouse lung tumor susceptibility
locus first mapped in A/J mice, appears to have a human
counterpart which also conveys susceptibility to the devel-
opment of human lung adenocarcinoma [14,15]. These
data suggest that findings in the welding fume-exposed A/
J mouse lung tumor model may have direct relevance to
humans. In addition, although welding fume-induced
lung toxicity has been investigated using other rodent
models, the direct comparison of a lung tumor susceptiblePage 8 of 16
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tionship between lung inflammation and possible weld-
ing fume-induced tumorigenesis.
Stainless steel electrodes used during MMA or GMA weld-
ing generate fumes containing carcinogenic Cr and Ni. A
major difference between the MMA- and GMA-generated
fumes is the solubility and, therefore, possibly the bioa-
vailability of the metals contained in the fumes. Indeed,
regardless of fume generation, stainless steel fumes report-
edly are toxic and mutagenic to mammalian cells [16,17],
cause DNA strand breaks in vitro and increased apoptosis
in vivo [18], and induce lung cell hyperplasia and atypia in
mice [19]. Furthermore, previous data showed the soluble
fraction of MMA-SS, which is abundant in Cr, generated
free radicals and caused significant lung macrophage tox-
icity [9,20]. Therefore, S-Cr was used to investigate the
acute lung toxicity of this metal, which has been impli-
cated as the main reactive component of MMA-SS fume
[10].
In the C57BL6/J strain, S-Cr appeared to be the main
pneumotoxic component as the markers of lung injury
and inflammation were not markedly different when
compared to exposure to MMA-SS fume at all time points
post-exposure. Conversely, the A/J exhibited a greater lung
Photomicrographs of lung tissue from welding fume-exposed A/J miceFigure 4
Photomicrographs of lung tissue from welding fume-exposed A/J mice. Preneoplastic lesions (panel A) and adeno-
mas (panel B) were the most common lung lesions observed in all exposed and sham groups. These representative low magni-
fication photomicrographs were captured at 48 weeks post-exposure to GMA-SS fume. Panel C is a high magnification 
photomicrograph showing the presence of GMA-SS fume (brown-black granular pigmented areas) at 48 weeks post-exposure. 
An increased persistence in the lung was observed for GMA-SS fume compared to the GMA-MS or MMA-SS fume. At 78 
weeks post-exposure, the presence of GMA-SS fume is still observed in the lung and an increased lymphohistiocytic infiltrate 
was associated with this fume (panel D).Page 9 of 16
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nents such as the insoluble Ni, Mn, and Fe, in addition to
S-Cr, exert toxic lung effects. Because chromium, in its
hexavalent form, rapidly penetrates lung cells and is
detoxified as it travels through the body [21,22], it is pos-
sible that an earlier time post-exposure may have revealed
a response similar to the C57BL/6J in the A/J strain. In
rats, previous time course data showed lung cytotoxicity
and damage caused by intratracheal exposure to the insol-
uble or soluble fraction, or the total MMA-SS fume were
similar at 3 hours and 1 day, but by 3 days the total fume
caused additive effects in the lung compared to the sepa-
rate fractions [20]. This divergent response in the rat
appears to resemble that of the A/J, but not the C57BL/6J,
in this study. Taken together, these data suggest that inter-
actions between the fume fractions are an important fea-
ture of MMA-SS lung toxicity, at least in Sprague-Dawley
rats and A/J mice.
Repeated exposure to the insoluble GMA-MS fume
revealed a strain-dependent neutrophil influx (A/J >
C57BL/6J) that persisted through 28 days. It appears the
insoluble components in welding fume – predominantly
Fe and Mn – may impact recruitment of lung PMN in A/J
mice, a phenomenon also observed in rats [20]. GMA-MS
exposure also caused slightly greater cytotoxicity in the A/
J, apparent only at 7 days, but no lung damage in either
strain. In agreement, intratracheal instillation of MS weld-
ing fume in rats, at a single bolus dose of 8 mg/kg, was
associated with the least lung toxicity when compared to
GMA-SS and MMA-SS fumes [20]. The magnitude of the
lung response to GMA-SS fume in the A/J was, overall,
also greater compared to the C57BL/6J strain. In contrast
to the GMA-MS fume, significant lung cell death and epi-
thelial damage were observed in both strains, but the lung
effects of the GMA-SS fume were greater, and the recovery
period longer, in the A/J strain. This suggests the GMA-SS
fume may cause a more chronic lung response likely
related to its increased persistence compared to the GMA-
MS [23] and the possible sensitivity of the A/J strain to the
insoluble Cr and Ni metal components of this fume.
For further confirmation of the BAL findings, key
cytokines, reportedly involved in welding fume-induced
lung inflammation, were evaluated [20]. The cytokine
response profiles, both gene expression and protein meas-
urements, mirrored the BAL profiles and revealed that the
lung response to aspirated MMA-SS and S-Cr involved the
pro-inflammatory cytokines IL-6, MCP-1, and TNF-α in
both strains. Similarly, IL-6, MCP-1, and TNF-α were com-
mon between the strains after GMA-SS fume exposure and
the response profiles also reflected that of the BAL. Again,
GMA-SS exposure appeared to cause a prolonged effect in
the A/J, evidenced by the persistent MCP-1 levels, which
may indicate an ongoing macrophage migration to the
lung. GMA-MS fume selectively increased lung TNF-α lev-
els in the A/J mice only, further suggesting that, in com-
parison to the other welding fumes, it is associated with
less lung activation. Of interest was the differential induc-
tion of IFN-γ, a potent macrophage-activating T helper 1
(Th1) cytokine. This cytokine was solely induced by the SS
fumes and only in the A/J strain. No measurable IFN-γ
protein was detected in the MMA-SS-exposed C57BL/6J
but a modest increase in gene expression was detected.
IFN-γ is produced exclusively by Th1 CD4 and CD8 cyto-
toxic T lymphocyte (CTL) effector cells and natural killer
(NK) cells. Its antiproliferative, antitumor, and immu-
nomodulatory properties have been extensively reviewed
[24]. The relevance of our finding that IFN-γ is selectively
increased following SS welding fume exposure – primarily
Table 4: Lung histopathology for A/J mice 48 and 78 Weeks post-exposure
Exposure n Lymphoid Infiltrates* Welding Fume-Laden Cells Lung Tumor Multiplicity† Lung Tumor Incidence‡
48 wk Sham 21 1.08 ± 0.16 0 ± 0 0.55 ± 0.14 50%
GMA-MS 24 0.30 ± 0.10 0.34 ± 0.10§ 0.38 ± 0.12 33%
GMA-SS 20 1.23 ± 0.22 3.03 ± 0.13§ 0.75 ± 0.15 65%**
MMA-SS 24 0.90 ± 0.16 0.67 ± 0.13§ 0.38 ± 0.12 33%
78 wk Sham 19 1.53 ± 0.29 0 ± 0 1.47 ± 0.33 68%
GMA-MS 20 0.78 ± 0.24 0.15 ± 0.07§ 1.40 ± 0.32 75%
GMA-SS 16 2.53 ± 0.36§ 1.12 ± 0.17§ 1.94 ± 0.38 88%
MMA-SS 20 1.70 ± 0.27 0.55 ± 0.19§ 1.85 ± 0.46 75%
*Perivascular/peribronchial associated lymphocytes, macrophages, and plasma cells.
†Average number of tumors/preneoplastic lesions per lung, includes mice with no lesions.
‡Percentage of tumor/preneoplasia-bearing mice out of the total. §Significantly increased compared to sham (p < 0.05). ||Significantly increased 
compared to GMA-MS and MMA-SS welding fumes (p < 0.05). **Significantly increased versus GMA-MS (p ≤ 0.05).
Note: Abbreviations are GMA-MS-gas metal arc-mild steel, GMA-SS-gas metal arc stainless steel, or MMA-SS-manual metal arc stainless steel 
welding fume. Data are mean ± SE.Page 10 of 16
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cytotoxic T cells and NK cells in the immune response to
SS welding fume in the A/J.
The recovery of the A/J lung response to welding fume,
assessed via BAL, was attenuated when compared to the
C57BL/6J strain. In fact, at 78 weeks after exposure, his-
topathology of the A/J lung showed that GMA-SS welding
fume continued to exert significant, but mild, inflamma-
tory lung effects, i.e. lung lymphoid infiltrates, which may
be correlated with its increased biopersistence compared
to the other fumes. In regards to tumorigenic effects, the
insoluble Cr and Ni components of this fume may be of
even greater importance given that the insoluble, iron-
abundant, GMA-MS and soluble chromium-containing
MMA-SS fume showed no consistent trends for incidence
or multiplicity in this mouse model. In fact, negative or
weak effects of soluble chromium on in vivo tumorigenic-
ity has been reported which seems to be consistent with
our preliminary results [21,25]. Further study is necessary
to completely understand the importance of our current
observations, but support exists for a relationship
between genetic susceptibility to lung tumorigenesis and
inflammation. To date, the mechanism(s) remain
unknown by which Pas1 confers lung tumor susceptibil-
ity. Anti-inflammatory drugs have been shown to inhibit
tumorigenesis in A/J mice, which suggests inflammation
and tumorigenesis may be linked [26]. Our long term pre-
liminary findings which showed gross tumor incidence,
but not multiplicity, to be nearly significant (p = 0.057),
when considered in conjunction with the BAL results and
histopathology, suggest that a chronic lung response to
GMA-SS welding fume may enhance tumorigenesis in the
A/J model. Certainly, more animal studies are needed to
clearly define if welding fume causes lung tumorigenesis
and which metal constituents, or combination thereof,
play a greater role.
It is reported that A/J mice begin to develop spontaneous
pulmonary tumors at 12–16 weeks of age [27]. Grossly
observed background tumor frequency, as reported in the
literature, can range from 31–40% between 43–53 weeks
of age and increase to 65% by approximately 66 weeks
[28-30]. Microscopically, adenomas and proliferations
are the most commonly observed pathologies of both
spontaneous and chemically-induced lung lesions in the
A/J mouse [31]. Our preliminary results regarding tumor
frequency and pathology are largely in agreement with
those stated in the literature. We observed that the major-
ity of the lung lesions in the sham and exposed groups
were preneoplastic epithelial proliferations, adenomas,
and/or adenomas arising within proliferations. In
humans, lung cancers are more histologically diverse
compared to the mouse, and adenocarcinomas are the
more common diagnosis [32]. In A/J mice, the production
of lung adenomas in is in fact relevant to the production
of lung adenocarcinomas in humans as it appears that
lung adenomas are the direct precursor to lung adenocar-
cinomas. Furthermore, in most cases, human and A/J
mouse lung tumors both originate from atypical hyper-
plastic foci in the lung periphery [33-36]. Our observed
background tumor frequency was 33% at 55 weeks of age
and 50% at 85 weeks upon gross exam. Although this
model is useful in many respects, the spontaneous tumor
rate in the A/J model is an obvious limitation and, when
combined with the observed mortality in this study,
reduced our statistical power for detecting differences to
only 50%. However, the tendency for the GMA-SS group
to consistently have the greatest lung tumor incidence and
multiplicity – both histopathologically and grossly
observed – is difficult to ignore. Although this fume does
not appear to be an exceedingly potent carcinogen at our
cumulative exposure dose of 340 μg, which is representa-
tive of an approximately 196 day exposure in a 75 kg
human, further investigation is indeed warranted. Cur-
rently, inhalation studies are ongoing using our recently
developed automated robotic welder [37] with signifi-
cantly larger group sizes to better control for the back-
ground incidence and to confirm our preliminary results
with the GMA-SS fume.
Welding generates a complex mixture of particles and gas-
eous by-products; thus, it is not remarkable that notable
differences are observed between the lung response fol-
lowing instillation of the fume and inhalation [38]. In
fact, it is shown that freshly generated SS welding fumes
are more biologically reactive compared to "aged" fumes,
such as those used in this study [39]. This decreased reac-
tivity may explain why there was no increased gene
expression for the selected markers of oxidative stress in
this study. Inhalation also more adequately mimics an
occupational exposure, and daily exposures in the auto-
mated welder will allow for a greater and more gradual
accumulation of fume in the mouse lung. Such an expo-
sure is difficult to achieve with pharyngeal aspiration as
repeated exposures are labor intensive in a study with
such large group sizes. Therefore, it is apparent that the
ongoing inhalation studies may offer more insight into
the toxicity and tumorigenicity of welding fumes.
Methods
Animals
Male C57BL/6J and A/J mice, 4 weeks of age were pur-
chased from Jackson Laboratories (Bar Harbor, ME) and
housed in an AAALAC-accredited, specific pathogen-free,
environmentally controlled facility. All mice were free of
endogenous viral pathogens, parasites, mycoplasmas,
Helicobacter, and CAR Bacillus. Mice were individually
housed in ventilated cages and provided HEPA-filtered air
under a controlled light cycle (12 hour light/12 hourPage 11 of 16
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relative humidity. Animals were acclimated to the animal
facility for a minimum of one week and allowed access to
a conventional diet (6% Irradiated NIH-31 Diet, Harlan
Teklad, Madison, WI) and tap water ad libitum. All proce-
dures were performed using protocols approved by the
National Institute for Occupational Safety and Health
Institutional Animal Care and Use Committee.
Welding fume collection and characterization
The welding fumes used in this study were provided by
Lincoln Electric Co., (Cleveland, OH). The collection and
characterization of these fumes were previously described
[9]. Briefly, the fumes were generated in a cubical open-
front fume chamber (volume = 1 m3) by a skilled welder,
using a manual or automatic technique appropriate for
the electrode, and then collected on a sterile 0.2 μm filter.
The samples were generated by three welding processes:
gas metal arc welding (with argon and CO2 shielding
gases) using a mild steel electrode; gas metal arc welding
using a stainless steel electrode; and manual metal arc
welding using a flux-cored stainless steel electrode.
Reported in Table 5 are the metal constituents, solubility/
insolubility ratio, and pH of each welding fume sample
[9]. Seven different metals (Cr, Cu, Fe, Mn, Ni, Ti, and V)
commonly found in welding fumes were measured using
inductively coupled argon plasma atomic emission spec-
troscopy. Count mean diameters were 1.22, 1.38, and
0.92 μm for the GMA-MS, GMA-SS, and MMA-SS samples,
respectively, as determined by electron microscopy [9].
Welding fume and soluble chromium preparation
Each welding fume was weighed and suspended in sterile
Ca+2 and Mg+2-free phosphate buffered saline (PBS) in a
50 ml sterile conical tube. Following the initial prepara-
tion, the fume samples were vortexed then sonicated for 1
minute using a Sonifier 450 Cell Disruptor (Branson
Ultrasonics, Danbury, CT). Prior to dosing, the samples
were vortexed then sonicated for 15 seconds and vortexed
immediately before each mouse exposure. For each exper-
imental time point, fresh welding fume suspensions were
made and the same preparation was used to expose both
strains of mice.
Soluble chromium in the form of sodium dichromate
dihydrate (Na2Cr2O7·2H2O) (Sigma-Aldrich, St. Louis,
MO) was used to represent the hexavalent chromium spe-
cies found in the MMA-SS fume as shown in previous
studies [20,40]. For each experimental time point, fresh
Na2Cr2O7·2H2O was weighed into a sterile 50 ml conical
tube, suspended in sterile PBS then vortexed. The same
preparation was used to expose both strains of mice.
Mouse pharyngeal aspiration exposure
Age and weight-matched A/J and C57BL/6J mice were
exposed to GMA-MS, GMA-SS, MMA-SS, S-Cr, or sterile
Ca+2 and Mg+2-free PBS (vehicle control) by pharyngeal
aspiration as previously described [41]. Briefly, each
mouse was placed in a glass jar with a gauze pad mois-
tened with isoflurane (Abbott Laboratories, North Chi-
cago, IL) until slowed breathing was observed. The mouse
was then suspended, by its top incisors, on a slanted
board in a supine position. The tongue was extended with
forceps and the solution was placed by pipette at the back
of the throat. The tongue was held extended until the solu-
tion was aspirated into the lung and the mouse resumed a
regular breathing pattern. When performed properly, this
technique allows minimal sample loss to the digestive
tract. The mouse was then returned to its cage to recover,
typically 10–15 seconds.
In this study, mice were exposed over a 10 day period to
four bolus doses of test material in lieu of a single bolus
dose. This regime achieved an accumulation of particles in
Table 5: Welding fume characterization by ICP-AES*
Welding Fume Sample Metal (weight %)† Soluble/insoluble Ratio pH
GMA-MS




























*Inductively Coupled Argon Plasma Atomic Emission Spectroscopy. † Relative to all metals analyzed. Note. Abbreviations are Cr-chromium; Fe-iron; 
Mn-Manganese; Ni-nickel. Data presented are referenced from Antonini et al., 1999.Page 12 of 16
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an occupational exposure. Mice were exposed four times
(once every 3 days) to 85 μg (~5 mg/kg) of GMA-MS,
GMA-SS, or MMA-SS welding fume, or 25.5 μg (~1.5 mg/
kg) S-Cr. The cumulative fume lung burden was derived
from our previous pharyngeal aspiration experiment in
the A/J mouse and is equivalent to ~196 days of exposure
in a 75 kg welder working an eight hour shift [19]. The
dose of S-Cr was equal to the weight % of Cr (~30%)
found in the MMA-SS total suspension (Table 5). A 25 μl
aspiration volume was used and shams were administered
an equal volume of PBS. Mice were sacrificed 2, 7 and 28
days post the fourth exposure. For the tumor study, A/J
mice (n = 25/group) were exposed using the same proto-
col to GMA-MS, GMA-SS, or MMA-SS welding fume and
sacrificed 48 and 78 weeks after the fourth exposure. S-Cr
was not included as a group in the tumor study because
our main objective was to first examine the effects of weld-
ing fumes, not their components.
Urethane exposure
Urethane (Acros Organics N.V., Fair Lawn, NJ, CAS#51-
79-6) served as a positive control for confirmation of A/J
tumor susceptibility in this study. A single i.p. dose of ure-
thane (0.75 g/kg) was administered to two independent
A/J vendor lots. The positive control group was run in par-
allel with the control and welding fume-exposed groups
for both the 48 week (n = 25) and 78 week (n = 20) time
points.
Body weight determination
For the comparative strain study, mice were weighed after
the one week acclimation period, throughout the dosing,
and again at the 2, 7, and 28 day sacrifices. The average
body weight after the final exposure was approximately 17
± 0.53 g for both mouse strains. All groups gained weight
throughout the study and no treatment effects were
observed.
A/J mice kept for 48 and 78 weeks post-exposure were
weighed after the one week acclimation period, during
dosing, and every 4 weeks until sacrifice. The average body
weight (± SE) at the start of the study for the sham and
welding fume groups was 18.9 ± 0.17 g and 18.4 ± 0.20 g
for the 48 and 78 week groups, respectively.
Bronchoalveolar lavage
BAL of the whole lung was used to assess lung inflamma-
tion and injury at 2, 7, and 28 days post-exposure to vari-
ous welding fumes or S-Cr in A/J and C57BL/6J mice. Mice
were deeply anesthetized with Sleepaway [26% sodium
pentobarbital, 7.8% isopropyl alcohol and 20.7% propyl-
ene glycol] (Fort Dodge Animal Health, Fort Dodge, IA)
then weighed. Once unresponsive, the abdomen was
opened and the vena cava was exsanguinated. For BAL, the
trachea was cannulated with a blunted 22 gauge needle
and, while massaging the thorax, 0.6 ml of cold PBS was
slowly instilled into the lung then withdrawn and placed
into a 15 ml conical tube. This constituted the first frac-
tion BAL fluid. Two subsequent lavages (1.0 ml/instillate)
were collected into a separate tube which represented the
second fraction. The BAL fluid was preserved on ice until
four animals were sacrificed then the samples were centri-
fuged (500 × g, 10 min, 4°C).
Aliquots of the first fraction BAL supernatant were used to
assess lung injury or frozen at -80°C for later analysis. The
supernatant of the second fraction was discarded. The cell
pellets from both fractions were combined and centri-
fuged (500 × g, 6 minutes, 4°C) and the supernatant dis-
carded. The final cell pellet was suspended in a known
volume of PBS and used for cell enumeration and differ-
ential staining.
Total cell numbers were determined using a Coulter Mul-
tisizer II and AccuComp software (Coulter Electronics,
Hialeah, FL). For differential staining, BAL cells were
plated onto glass slides using a Cytospin 3 centrifuge
(Shandon Life Sciences International, Cheshire, England)
set at 800 rpm for 5 minutes. Slides were stained using
Leukostat stain (Fisher Scientific, Pittsburgh, PA) then
coverslipped. A minimum of 300 cells/slide consisting of
alveolar macrophages/monocytes, lymphocytes, or PMN
were identified using light microscopy. Slides from shams
consisted typically of > 99% alveolar macrophages.
Bronchoalveolar lavage fluid cytokine analysis
Concentrations of cytokines from the first fraction BAL
supernatant were measured using a mouse inflammation
cytometric bead array kit (BD Biosciences, San Diego, CA)
and analyzed on a FACSCalibur flow cytometer as previ-
ously described [42]. The following cytokines were meas-
ured: IL-6, IL-10, MCP-1, IFN-γ, TNF-α and IL-12p70.
Standard curves with a range of 20–5,000 pg/ml were
determined for each cytokine. The sensitivity of the assay
for each protein ranged from 2.5–52.7 pg/ml. Because
BAL protein levels for some analytes were at or below
assay sensitivity, which limited statistical analysis, confir-
mation of selected BAL profiles by real-time reverse tran-
scription polymerase chain reaction (RT-PCR) [see below]
was done [42]. To appropriately represent the protein
data, a scatter plot was chosen with the mean values indi-
cated for each group.
Biochemical measurements
Albumin, a measure of damage to the lung alveolar epi-
thelial barrier, and LDH activity, indicative of lung cell
death, were measured in the first fraction BAL fluid super-
natant. The albumin concentration was determined color-
imetrically at 628 nm based on albumin binding toPage 13 of 16
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(Sigma Chemical Co., St. Louis, MO). LDH activity was
determined by measuring the oxidation of lactate to pyru-
vate coupled with the formation of NADH at 340 nm.
Both measurements were performed with a COBAS MIRA
Plus auto-analyzer (Roche Diagnostic Systems, Montclair,
NJ).
Real-Time RT-PCR
In separate identical experiments, whole lungs were
removed from sham and welding fume-exposed mice
then snap frozen in liquid nitrogen and stored at -80°C
for RNA isolation. RNA was isolated from whole lung
homogenates using the TRIzol (Invitrogen, Carlsbad, CA)
method and then cleaned according to the manufacturer's
instructions using a RNeasy Mini Kit (Qiagen, Valencia,
CA) to remove possible DNA contamination. One μg of
total RNA was reverse-transcribed using random hexam-
ers (Applied Biosystems, Foster City, CA) and Superscript
II (Invitrogen, Carlsbad, CA). Five μl of cDNA (in dupli-
cates for each gene) was then used for gene expression
determination using the Applied Biosystems 7900HT
(Foster City, CA). The ribosomal subunit 18S was used as
the housekeeping gene (Hs99999901_s1, Applied Biosys-
tems). Relative gene expression was calculated using the
comparative threshold method (2-ΔΔCt) [43].
The cytokine bead array findings from the MMA-SS 2 and
7 day post-exposure time points only were verified using
the following Pre-designed Assays-on-Demand™ TaqMan®
probes and primers from Applied Biosystems: IFN-γ
(Mm00801778_m1), IL-6 (Mm00446190_m1), MCP-1
(Mm00441242_m1), and TNF-α (Mm00443258_m1).
The following oxidative stress markers were also evaluated
using RT-PCR: NOS2 or iNOS [Mm00440485_m1], COX-
2 [Mm00440485_m1], and GST-Pi [Mm00839138_g1].
Gross tumor counts and histopathology
A/J mice were euthanized by carbon dioxide asphyxiation,
weighed, then the abdomen was opened and the vena
cava exsanguinated. The whole lung was excised and gross
tumor counts and measurements were recorded for each
lung lobe. Apparent merged tumors, defined as a single
tumor pattern in double-nodule form or an apparent col-
lision of two different tumors, were counted as one
because this was impossible to distinguish at necropsy.
The lungs were inflated and fixed with 10% neutral buff-
ered formalin for a minimum of 24 hours. Each lung lobe
(apical, azygos, cardiac, diaphragmatic, left) was sepa-
rately embedded in paraffin then a 5 μm standardized sec-
tion was cut from each lung lobe. Slides were stained with
hematoxylin and eosin and interpreted by a contracted
board certified veterinary pathologist in a blinded fashion
for morphological changes and proliferative/neoplastic
lesions. If abnormal changes were found, severity was
scored as follows: 1 = minimal, 2 = mild, 3 = moderate, 4
= marked, 5 = severe. The final severity score reflects the
average of the right and left lung lobe scores. Proliferative/
neoplastic changes were scored as P = preneoplastic epi-
thelial proliferation, AP = adenoma arising within a pro-
liferation, A = adenoma, CA = carcinoma arising within an
adenoma, C = carcinoma, or MC = microcarcinoma
according to Belinksy et al. [33]. Since examination of a
single histological section per lung underestimates the
total number of lesions per lung [44], the gross count at
necropsy would be more representative of the response.
However, for completeness, both microscopic and gross
exam were statistically evaluated in this study. His-
topathological interpretation was not done on lung sec-
tions from urethane-exposed mice because this was
previously reported and was not our purpose [45,46].
Statistical comparisons and analysis
For the 2, 7, and 28 day study, the mouse exposures were
designed to account for the following statistical compari-
sons: 1) MMA-SS versus S-Cr and 2) GMA-MS versus
GMA-SS between the two mouse strains within a single
time point. Therefore, the exposures for each experimen-
tal time point (2, 7, or 28 days post-exposure) were run in
parallel with both strains and shams were run with every
exposure. Statistical comparisons were not made between
different time points post-exposure or between the MMA-
SS and GMA welding fumes.
All analyses were performed either using JMP version
5.0.1, or the SAS system for Windows version 9.1 (SAS
Institute, Cary, NC). Factorial analysis of variance
(ANOVA) was utilized on continuous variables to incor-
porate strain and treatment into each analysis. For some
variables a log transformation was performed on the data
to reduce heterogeneous variance and meet the assump-
tions of the ANOVA. All post-hoc comparisons were car-
ried out using Fishers Least Significant Difference Test. For
all analyses, the criterion of significance was p < 0.05.
Gross tumor counts and histopathology counts from sec-
tions were analyzed similarly. Tumor incidence (presence
or absence of tumors) was analyzed using a Chi-Square
test in SAS 'Proc Freq', while tumor multiplicity (number
of tumors/lung) was analyzed using Poisson regression in
SAS 'Proc Genmod'. All analyses on tumor data utilized
only those animals surviving the complete 48 and 78
week time points.
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